Minimum 5 year follow-up of clinical and radiographic results of cemented acetabular components with an interface bioactive bone cement technique in primary cemented total hip arthroplasty. Arch Orthop Trauma Surg 141, 139–147 (2021).

Minimum 5 year follow-up of clinical and radiographic results of cemented acetabular components with an interface bioactive bone cement technique in primary cemented total hip arthroplasty

Miyamoto, S., Iida, S., Suzuki, C. et al.
Hip

Introduction

A well-fixed cement–bone interface is a crucial factor for acetabular and femoral components in cemented total hip arthroplasty (THA). The aim of the present study was to evaluate the middle-term clinical and radiological results of fixing the acetabular component with an interface bioactive bone cement (IBBC) technique in primary cemented THA.

Materials and methods

We undertook a retrospective review was undertaken of 193 primary cemented THAs in 174 patients using acetabular components cemented with an IBBC technique and followed for a minimum of 5 years (mean 8.3 years; range 5–17 years). Baseline data, clinical and radiological outcomes were evaluated.

Results

Japanese Orthopedic Association hip score and modified Harris hip scores demonstrated significant clinical improvement in all patients (p < 0.001). Radiolucent lines were detected in 15 hips (7.8%) at the first year and 24 hips (12.4%) at the final post-operative follow-up. The Kaplan–Meier survivorship with radiographic loosening as the end point was 97.8% [95% confidence interval (CI) 95.2–100]. With revision of the acetabular component for aseptic loosening as the end point, component survival was 99.0% (95% CI 97.5–100). With revision of the acetabular component for any reason as the end point, component survival was 97.0% (95% CI 93.9–100).

Conclusions

Clinical and radiological results of the acetabular component with the IBBC technique in primary cemented THA were excellent.


Download article